NAT10 and colorectal cancer: Clinical translational studies revealed that NAT10 expression levels exhibit significantly positive correlations with MN generation frequency and SASP pathway activity in colorectal cancer cohorts, with coordinated elevation of these parameters in tumors exhibiting poor differentiation, advanced TNM stages, and high metastatic potential.